Unnamed: 0,title,date,stock,sentiment
956720.0,Onconova Therapeutics Filing Shows Board Expects To Withdraw Reverse Stock Split Proposal For Annual Shareholder Meeting,2020-06-10 17:42:00-04:00,ONTX,neutral
956721.0,Onconova Therapeutics shares are trading higher after the company reported better-than-expected Q1 EPS results.,2020-05-15 08:45:00-04:00,ONTX,positive
956722.0,Maxim Upgrades Onconova From Hold To Buy,2020-05-15 07:58:00-04:00,ONTX,neutral
956723.0,"Onconova Therapeutics Q1 EPS $(0.030) Beats $(0.050) Estimate, Sales $52.000K May Not Compare To $150.000K Estimate",2020-05-14 16:17:00-04:00,ONTX,neutral
956724.0,"The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse Merger",2020-05-14 08:32:00-04:00,ONTX,positive
956725.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,ONTX,negative
956726.0,"The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight",2020-05-10 15:40:00-04:00,ONTX,neutral
956727.0,18 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-30 07:35:00-04:00,ONTX,neutral
956728.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-03-25 07:35:00-04:00,ONTX,neutral
956729.0,"The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down",2020-03-25 07:29:00-04:00,ONTX,neutral
956730.0,Onconova Therapeutics Announces Completion Of Enrollment Of Phase 3 INSPIRE Trial,2020-03-24 16:06:00-04:00,ONTX,positive
956731.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,ONTX,negative
956732.0,"The Week Ahead In Biotech: Bristol-Myers, Rockwell Medical Await FDA Decisions, COVID-19 Updates In Focus",2020-03-22 14:25:00-04:00,ONTX,positive
956733.0,Onconova Therapeutics Granted US Patent Titled 'Methods and compositions for treatment of cancer',2020-03-03 09:57:00-05:00,ONTX,negative
956734.0,50 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-02-28 08:34:00-05:00,ONTX,neutral
956735.0,25 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-02-24 07:39:00-05:00,ONTX,neutral
956736.0,80 Biggest Movers From Yesterday,2020-02-19 04:28:00-05:00,ONTX,neutral
956737.0,46 Stocks Moving In Tuesday's Mid-Day Session,2020-02-18 12:23:00-05:00,ONTX,neutral
956738.0,30 Stocks Moving in Tuesday's Pre-Market Session,2020-02-18 07:13:00-05:00,ONTX,neutral
956739.0,52 Stocks Moving In Wednesday's Mid-Day Session,2020-02-12 12:13:00-05:00,ONTX,neutral
956740.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-12 07:35:00-05:00,ONTX,neutral
956741.0,12 Biotechnology Stocks Moving In Wednesday's Pre-Market Session,2020-02-12 07:33:00-05:00,ONTX,neutral
956742.0,31 Stocks Moving in Wednesday's Pre-Market Session,2020-02-12 07:15:00-05:00,ONTX,neutral
956743.0,"Onconova Therapeutics Shares Up 9% Over Last Few Mins.; Co. Pres, CEO To Present Update At BIO CEO, Investor Conference Tues.",2020-02-11 09:15:00-05:00,ONTX,positive
956744.0,8 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-02-11 07:37:00-05:00,ONTX,neutral
956745.0,6 Biotechnology Stocks Moving In Tuesday's Pre-Market Session,2020-02-11 07:35:00-05:00,ONTX,neutral
956746.0,80 Biggest Movers From Yesterday,2020-02-11 04:44:00-05:00,ONTX,neutral
956747.0,58 Stocks Moving In Monday's Mid-Day Session,2020-02-10 12:14:00-05:00,ONTX,neutral
956748.0,12 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-02-10 07:51:00-05:00,ONTX,neutral
956749.0,8 Biotechnology Stocks Moving In Monday's Pre-Market Session,2020-02-10 07:50:00-05:00,ONTX,neutral
956750.0,30 Stocks Moving in Monday's Pre-Market Session,2020-02-10 07:30:00-05:00,ONTX,neutral
956751.0,90 Biggest Movers From Yesterday,2020-02-06 05:15:00-05:00,ONTX,neutral
956752.0,68 Stocks Moving In Wednesday's Mid-Day Session,2020-02-05 12:16:00-05:00,ONTX,neutral
956753.0,8 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-05 07:43:00-05:00,ONTX,neutral
956754.0,6 Biotechnology Stocks Moving In Wednesday's Pre-Market Session,2020-02-05 07:42:00-05:00,ONTX,neutral
956755.0,146 Biotechnology Stocks Moving In Thursday's Session,2020-01-23 12:47:00-05:00,ONTX,neutral
956756.0,Onconova Therapeutics shares are trading higher after the company announced it has regained the rights to rigosertib in Greater China.,2020-01-23 09:05:00-05:00,ONTX,positive
956757.0,Onconova Therapeutics Regains Rigosertib Rights In Greater China,2020-01-23 08:30:00-05:00,ONTX,positive
956758.0,98 Biotechnology Stocks Moving In Wednesday's Session,2020-01-22 13:33:00-05:00,ONTX,neutral
956759.0,21 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-10 07:38:00-05:00,ONTX,neutral
956760.0,20 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-01-07 07:53:00-05:00,ONTX,neutral
956761.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-01-06 07:38:00-05:00,ONTX,neutral
956762.0,34 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-03 07:45:00-05:00,ONTX,neutral
956763.0,21 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-01-02 07:49:00-05:00,ONTX,neutral
956764.0,Onconova Therapeutics Reports ~27.66M Share Common Stock Offering At $0.3615/Share,2019-12-31 11:30:00-05:00,ONTX,positive
956765.0,11 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-31 07:52:00-05:00,ONTX,neutral
956766.0,Onconova Therapeutics shares are trading higher. Not seeing any news to justify the price action.,2019-12-30 11:09:00-05:00,ONTX,positive
956767.0,38 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-12-30 08:21:00-05:00,ONTX,neutral
956768.0,31 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-12-27 08:13:00-05:00,ONTX,neutral
956769.0,28 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-12-20 08:19:00-05:00,ONTX,neutral
956770.0,Onconova Therapeutics shares are trading lower after the company announced a $5 million registered direct offering.,2019-12-18 09:49:00-05:00,ONTX,neutral
956771.0,"Onconova Therapeutics, Inc. Announces $5M Registered Direct Offering Priced At-the-Market",2019-12-18 09:18:00-05:00,ONTX,neutral
956772.0,Onconova Therapeutics Announces Exclusive License Agreement with Specialised Therapeutics for Rigosertib in Australia and New Zealand; Co. Eligible To Receive $30.4M In Milestones,2019-12-18 09:18:00-05:00,ONTX,positive
956773.0,19 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-17 07:57:00-05:00,ONTX,neutral
956774.0,Onconova Therapeutics shares are trading lower after the company announced the closing of its $5 million registered direct offering.,2019-12-11 11:06:00-05:00,ONTX,neutral
956775.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-12-11 07:54:00-05:00,ONTX,neutral
956776.0,41 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-10 08:10:00-05:00,ONTX,neutral
956777.0,48 Stocks Moving In Monday's Mid-Day Session,2019-12-09 12:26:00-05:00,ONTX,neutral
956778.0,"Onconova Therapeutics Highlights Data On Genomic Profiles Of Higher-Risk Myelodysplastic Syndromes Patients Refractory To Azacitidine Therapy Enrolled In INSPIRE Trial, Updated Oral Rigosertib Data At ASH",2019-12-09 09:07:00-05:00,ONTX,positive
956779.0,Onconova Therapeutics Shares Down 10% Premarket After Co. Announced Data Presented From INSPIRE Trial,2019-12-09 09:03:00-05:00,ONTX,positive
956780.0,38 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-12-09 08:26:00-05:00,ONTX,neutral
956781.0,Onconova Therapeutics Announces $5.0 Million Registered Direct Offering Priced at $0.349/Share and Warrant,2019-12-09 08:01:00-05:00,ONTX,neutral
956782.0,74 Biggest Movers From Friday,2019-12-09 05:22:00-05:00,ONTX,neutral
956783.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling",2019-12-07 08:35:00-05:00,ONTX,positive
956784.0,55 Stocks Moving In Friday's Mid-Day Session,2019-12-06 12:02:00-05:00,ONTX,neutral
956785.0,"Benzinga Pro's Top 5 Stocks To Watch For Fri., Dec. 6, 2019: TSLA, ONTX, XHB, BIG, SFIX",2019-12-06 08:49:00-05:00,ONTX,positive
956786.0,Onconova Therapeutics shares are trading higher after the company announced it has entered into a collaboration agreement with Inceptua Medicines Access to make available intravenous rigosertib via pre-approval access program in selected countries.,2019-12-06 07:45:00-05:00,ONTX,positive
956787.0,Onconova Therapeutics Reports Collaboration With Inceptua Medicines Access For Intravenous Rigosertib Via Pre-Approval Access Program,2019-12-06 07:37:00-05:00,ONTX,neutral
956788.0,Onconova Therapeutics shares are trading lower as a potential sell-off after the stock increased roughly 95% in the last 5 trading sessions. NOTE: Penny stocks can have volatile price action with no catalyst.,2019-12-05 11:05:00-05:00,ONTX,neutral
956789.0,Shares of nano-cap penny stock Onconova Therapeutics are trading higher on continued upward momentum. Not currently seeing any company-specific news. NOTE: Biotech names have been highly volatile this session.,2019-12-03 10:43:00-05:00,ONTX,positive
956790.0,19 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-03 07:46:00-05:00,ONTX,neutral
956791.0,Onconova Therapeutics 13G From Late Monday Shows Intracoastal Capital Holds 4.99% Stake In Co.,2019-12-03 06:42:00-05:00,ONTX,neutral
956792.0,44 Stocks Moving In Monday's Mid-Day Session,2019-12-02 12:11:00-05:00,ONTX,neutral
956793.0,Onconova Therapeutics shares are trading higher on seemingly no company-specific news. The stock is trading on higher-than-average volume. NOTE: Penny stocks can have volatile price action with no catalyst.,2019-12-02 10:26:00-05:00,ONTX,negative
956794.0,10 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-12-02 07:24:00-05:00,ONTX,neutral
956795.0,52 Biggest Movers From Friday,2019-12-02 04:44:00-05:00,ONTX,neutral
956796.0,35 Stocks Moving In Friday's Mid-Day Session,2019-11-29 11:40:00-05:00,ONTX,neutral
956797.0,Onconova Therapeutics shares are trading higher on seemingly no company-specific news.,2019-11-29 08:46:00-05:00,ONTX,neutral
956798.0,9 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-29 07:43:00-05:00,ONTX,neutral
956799.0,52 Biggest Movers From Wednesday,2019-11-29 05:26:00-05:00,ONTX,neutral
956800.0,33 Stocks Moving In Wednesday's Mid-Day Session,2019-11-27 11:41:00-05:00,ONTX,neutral
956801.0,Onconova Therapeutics shares are trading higher. Not seeing any news to justify the price action. NOTE: The company reported insider buying of 500K shares.,2019-11-27 08:55:00-05:00,ONTX,positive
956802.0,8 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-11-27 07:30:00-05:00,ONTX,neutral
956803.0,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",2019-11-27 07:26:00-05:00,ONTX,negative
956804.0,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",2019-11-26 08:06:00-05:00,ONTX,positive
956805.0,14 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-11-26 07:58:00-05:00,ONTX,neutral
956806.0,36 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-11-25 08:40:00-05:00,ONTX,neutral
956807.0,"The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate",2019-11-22 08:18:00-05:00,ONTX,positive
956808.0,19 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-22 07:47:00-05:00,ONTX,neutral
956809.0,Onconova Therapeutics Announces $11M Offering Of Common Stock And Warrants,2019-11-21 11:26:00-05:00,ONTX,neutral
956810.0,22 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-11-21 07:47:00-05:00,ONTX,neutral
956811.0,"The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon",2019-11-21 07:22:00-05:00,ONTX,positive
956812.0,"The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval",2019-11-15 07:08:00-05:00,ONTX,negative
956813.0,"The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing",2019-11-14 08:07:00-05:00,ONTX,positive
956814.0,Stocks That Hit 52-Week Lows On Wednesday,2019-11-13 10:50:00-05:00,ONTX,negative
956815.0,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",2019-11-13 07:10:00-05:00,ONTX,neutral
956816.0,Stocks That Hit 52-Week Lows On Tuesday,2019-11-12 10:52:00-05:00,ONTX,negative
956817.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,ONTX,neutral
956818.0,Stocks That Hit 52-Week Lows On Friday,2019-11-08 11:41:00-05:00,ONTX,negative
956819.0,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut",2019-11-08 08:14:00-05:00,ONTX,neutral
956820.0,Stocks That Hit 52-Week Lows On Thursday,2019-11-07 12:16:00-05:00,ONTX,negative
956821.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,ONTX,negative
956822.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-29 10:53:00-04:00,ONTX,negative
956823.0,28 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-29 08:33:00-04:00,ONTX,neutral
956824.0,"Onconova Therapeutics Files for Offering of Up to 16.9M Units, Consisting of One Share of Common Stock, and One Warrant to Purchase One Share of Common Stock",2019-10-29 06:08:00-04:00,ONTX,positive
956825.0,Stocks That Hit 52-Week Lows On Friday,2019-10-25 12:49:00-04:00,ONTX,negative
956826.0,Onconova Affirms Planned Completion Of Pivotal Phase 3 INSPIRE Study Of Rigosertib In Myelodysplastic Syndromes By 1H20 And Provides Research & Development Update,2019-10-24 07:45:00-04:00,ONTX,positive
956827.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Screener Tool For Tue., October 15, 2019",2019-10-15 14:05:00-04:00,ONTX,positive
956828.0,"The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout",2019-10-11 08:14:00-04:00,ONTX,positive
956829.0,"The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO",2019-10-10 07:31:00-04:00,ONTX,neutral
956830.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-09 12:55:00-04:00,ONTX,negative
956831.0,"The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug",2019-10-09 07:58:00-04:00,ONTX,negative
956832.0,"The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering",2019-10-04 07:32:00-04:00,ONTX,negative
956833.0,"The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines",2019-10-01 08:10:00-04:00,ONTX,negative
956834.0,Stocks That Hit 52-Week Lows On Monday,2019-09-30 11:20:00-04:00,ONTX,negative
956835.0,"The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J",2019-09-26 07:54:00-04:00,ONTX,positive
956836.0,Stocks That Hit 52-Week Lows On Wednesday,2019-09-25 11:56:00-04:00,ONTX,negative
956837.0,"The Daily Biotech Pulse: PhaseBio Leaps On Trial Results, Pacira Set To Join SmallCap 600 Index, Positive Readout For Amgen's Blood Cancer Drug",2019-09-25 07:13:00-04:00,ONTX,positive
956838.0,"The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger",2019-09-24 08:12:00-04:00,ONTX,positive
956839.0,46 Biggest Movers From Yesterday,2019-09-24 04:02:00-04:00,ONTX,neutral
956840.0,Mid-Afternoon Market Update: Dow Rises Over 50 Points; Avadel Pharmaceuticals Shares Spike Higher,2019-09-23 15:05:00-04:00,ONTX,positive
956841.0,Stocks That Hit 52-Week Lows On Monday,2019-09-23 13:35:00-04:00,ONTX,negative
956842.0,34 Stocks Moving In Monday's Mid-Day Session,2019-09-23 12:37:00-04:00,ONTX,neutral
956843.0,Mid-Day Market Update: Reebonz Falls Following First-Half Results; Plus Therapeutics Shares Climb,2019-09-23 12:37:00-04:00,ONTX,positive
956844.0,Mid-Morning Market Update: Markets Open Lower; Greenbriar To Acquire Arotech,2019-09-23 10:08:00-04:00,ONTX,negative
956845.0,"Onconova Therapeutics Reports ~2.136M Share Registered Direct Offering Of Common Stock, Priced At $1.60/Share",2019-09-23 08:53:00-04:00,ONTX,positive
956846.0,"The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO",2019-09-19 07:39:00-04:00,ONTX,neutral
956847.0,36 Stocks Moving In Wednesday's Mid-Day Session,2019-09-18 13:19:00-04:00,ONTX,neutral
956848.0,"Onconova Therapeutics Shares Resume Trade, Up 20%",2019-09-18 10:10:00-04:00,ONTX,positive
956849.0,Onconova Therapeutics Terminates Offering,2019-09-18 10:06:00-04:00,ONTX,neutral
956850.0,"Onconova Therapeutics Shares Halted On Circuit Breaker, Up 15.6% For Session",2019-09-18 10:05:00-04:00,ONTX,positive
956851.0,10 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-09-18 08:13:00-04:00,ONTX,neutral
956852.0,65 Biggest Movers From Yesterday,2019-09-18 06:53:00-04:00,ONTX,neutral
956853.0,Onconova Therapeutics shares are trading lower after the company's filing showed registration for common stock with no disclosed size.,2019-09-17 17:45:00-04:00,ONTX,negative
956854.0,"Onconova Therapeutics Filing Shows Registration For Common Stock, Series C Convertible Preferred Stock, No Size Disclosed",2019-09-17 17:43:00-04:00,ONTX,negative
956855.0,38 Stocks Moving In Tuesday's Mid-Day Session,2019-09-17 12:14:00-04:00,ONTX,neutral
956856.0,"Onconova Therapeutics shares are trading lower on continued momentum after Tyndall Capital sold 1,247 shares at an average price of $2.75 per share ahead of the Rigosertib data presentation.",2019-09-17 08:37:00-04:00,ONTX,positive
956857.0,70 Biggest Movers From Yesterday,2019-09-17 05:11:00-04:00,ONTX,neutral
956858.0,48 Stocks Moving In Monday's Mid-Day Session,2019-09-16 12:32:00-04:00,ONTX,neutral
956859.0,"Onconova Therapeutics Q2 EPS $(0.6) Beats $(0.82) Estimate, Sales $2.022M Beat $490K Estimate",2019-08-14 07:59:00-04:00,ONTX,neutral
956860.0,"The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering",2019-08-14 07:50:00-04:00,ONTX,negative
956861.0,Onconova Therapeutics And Mission Bio Announce Precision Oncology Partnership \,2019-08-12 07:32:00-04:00,ONTX,neutral
956862.0,Onconova Therapeutics Reports Partnership With Mission Bio To Advance Precision Oncology Trials Employing Single-Cell Genomics,2019-08-12 07:32:00-04:00,ONTX,neutral
956863.0,"The Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPO",2019-08-11 15:46:00-04:00,ONTX,positive
956864.0,64 Biggest Movers From Yesterday,2019-07-26 04:36:00-04:00,ONTX,neutral
956865.0,Onconova Therapeutics shares are trading higher after Noble Capital initiated coverage on the stock with an Outperform rating and a price target of $12 per share.,2019-07-25 15:47:00-04:00,ONTX,positive
956866.0,50 Stocks Moving In Thursday's Mid-Day Session,2019-07-25 13:22:00-04:00,ONTX,neutral
956867.0,"Benzinga's Top Upgrades, Downgrades For July 25, 2019",2019-07-25 09:48:00-04:00,ONTX,positive
956868.0,"Noble Capital Initiates Coverage On Onconova Therapeutics with Outperform Rating, Announces $12 Price Target",2019-07-25 09:30:00-04:00,ONTX,positive
956869.0,62 Biggest Movers From Yesterday,2019-06-28 05:20:00-04:00,ONTX,neutral
956870.0,Onconova Therapeutics Shares Resume Trade,2019-06-27 13:24:00-04:00,ONTX,positive
956871.0,Onconova Therapeutics Shares Halted On Circuit Breaker,2019-06-27 13:14:00-04:00,ONTX,positive
956872.0,"Companies Which Will Be Presenting At LD Micro's 9th Annual Micro Invitational Tues., Jun. 4, 2019",2019-06-03 16:57:00-04:00,ONTX,neutral
956873.0,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",2019-05-14 07:42:00-04:00,ONTX,positive
956874.0,"Onconova Therapeutics Q1 EPS $(1.29) Misses $(1.03) Estimate, Sales $68K Miss $80K Estimate",2019-05-14 07:34:00-04:00,ONTX,negative
956875.0,"Onconova Licenses its Rigosertib to HanX for Chinese Commercialization, Onconova to Receive a $4M Upfront Payment",2019-05-13 07:35:00-04:00,ONTX,neutral
956876.0,58 Biggest Movers From Yesterday,2019-03-27 04:22:00-04:00,ONTX,neutral
956877.0,"The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs",2019-03-26 07:36:00-04:00,ONTX,positive
956878.0,"Onconova Therapeutics FY18 EPS $(4.99) vs $(40.15) In FY17, Sales $1.228M vs $787K In FY17",2019-03-26 07:33:00-04:00,ONTX,neutral
956879.0,"Earnings Scheduled For March 26, 2019",2019-03-26 04:00:00-04:00,ONTX,neutral
956880.0,Onconova Achieves Over 75 Percent of Planned Enrollment in Pivotal Phase 3 INSPIRE Study of Rigosertib in Myelodysplastic Syndromes,2019-03-25 07:33:00-04:00,ONTX,positive
956881.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs",2019-03-23 12:20:00-04:00,ONTX,neutral
956882.0,75 Biggest Movers From Friday,2019-03-18 05:22:00-04:00,ONTX,neutral
956883.0,54 Biggest Movers From Yesterday,2019-02-12 04:44:00-05:00,ONTX,neutral
956884.0,64 Biggest Movers From Yesterday,2019-02-01 05:00:00-05:00,ONTX,neutral
956885.0,62 Biggest Movers From Yesterday,2019-01-31 05:06:00-05:00,ONTX,neutral
956886.0,48 Stocks Moving In Wednesday's Mid-Day Session,2019-01-30 12:39:00-05:00,ONTX,neutral
956887.0,48 Biggest Movers From Yesterday,2019-01-18 05:06:00-05:00,ONTX,neutral
956888.0,"Onconova Says Co. Is 'well-positioned to deliver key milestones in 2019 for both intravenous and oral rigosertib, as well as other pipeline products'",2019-01-15 17:17:00-05:00,ONTX,positive
956889.0,Onconova Therapeutics Promotes Dr. Steven M. Fruchtman To CEO,2019-01-15 17:15:00-05:00,ONTX,positive
956890.0,Onconova Submits Special Protocol Assessment To FDA for Phase 3 Trial Of Oral Rigosertib In Combination With Azacitidine For First-Line Myelodysplastic Syndromes,2019-01-02 07:34:00-05:00,ONTX,positive
956891.0,54 Biggest Movers From Yesterday,2018-12-27 05:55:00-05:00,ONTX,neutral
956892.0,60 Biggest Movers From Friday,2018-12-24 04:35:00-05:00,ONTX,neutral
956893.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,ONTX,neutral
956894.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,ONTX,positive
956895.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,ONTX,positive
956896.0,50 Biggest Movers From Yesterday,2018-12-18 06:11:00-05:00,ONTX,neutral
956897.0,"Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018",2018-12-14 11:03:00-05:00,ONTX,negative
956898.0,"The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch",2018-12-14 07:47:00-05:00,ONTX,neutral
956899.0,46 Stocks Moving In Monday's Mid-Day Session,2018-12-03 12:37:00-05:00,ONTX,neutral
956900.0,Onconova Highlights Results From Phase 2 Trial Of Oral Rigosertib In Combination With Azacitidine In Myelodysplastic Syndromes At 2018 ASH Annual Meeting,2018-12-03 07:37:00-05:00,ONTX,neutral
956901.0,"The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings",2018-11-25 09:41:00-05:00,ONTX,neutral
956902.0,35 Stocks Moving In Friday's Mid-Day Session,2018-11-23 12:25:00-05:00,ONTX,neutral
956903.0,Onconova Thearapeutics shares up 10% on heavy volume amid momentum in low-float issues. The stock has about 3.2 million shares in its float.,2018-11-23 10:22:00-05:00,ONTX,positive
956904.0,"Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018",2018-11-23 09:09:00-05:00,ONTX,negative
956905.0,50 Biggest Movers From Wednesday,2018-11-23 05:17:00-05:00,ONTX,neutral
956906.0,64 Biggest Movers From Yesterday,2018-11-16 04:58:00-05:00,ONTX,neutral
956907.0,"Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 14, 2018",2018-11-15 11:37:00-05:00,ONTX,negative
956908.0,"The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results",2018-11-15 08:10:00-05:00,ONTX,positive
956909.0,"The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut",2018-11-14 08:17:00-05:00,ONTX,neutral
956910.0,55 Biggest Movers From Yesterday,2018-11-14 04:06:00-05:00,ONTX,neutral
956911.0,"The Daily Biotech Pulse: Viking's Fatty Liver And Cholesterol Drug, Cyclacel Loss Narrows, Eton's Debut",2018-11-13 07:54:00-05:00,ONTX,negative
956912.0,"Onconova Therapeutics Q3 EPS $(0.94) Beats $(1.16) Estimate, Sales $120K Miss $670K Estimate",2018-11-13 07:28:00-05:00,ONTX,negative
956913.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-11 09:10:00-05:00,ONTX,neutral
956914.0,Onconova Thearpeutics Reports Issuance Of New US Patent For Rigosertib,2018-10-17 08:31:00-04:00,ONTX,neutral
956915.0,51 Biggest Movers From Yesterday,2018-09-28 05:15:00-04:00,ONTX,neutral
956916.0,30 Stocks Moving In Wednesday's Mid-Day Session,2018-09-26 12:32:00-04:00,ONTX,neutral
956917.0,"Onconova Therapeutics shares are up 30.4% after being halted, despite no company-specific news; NOTE: The stock begins trading on a 1-for-15 reverse stock split basis today and some platforms may show shares up over 1,700%, ignore.",2018-09-26 11:09:00-04:00,ONTX,positive
956918.0,Onconova Therapeutics Shares Resume Trade; Up 30.4%,2018-09-26 11:05:00-04:00,ONTX,positive
956919.0,"Onconova Therapeutics Shares Halted On Circuit Breaker, Up 19.6%",2018-09-26 11:00:00-04:00,ONTX,positive
956920.0,"Onconova Therapeutics Announces 1-for-15 Reverse Stock Split, Effective Sept. 25",2018-09-25 09:17:00-04:00,ONTX,positive
956921.0,"Onconova Therapeutics Announces Plan for Expanding Rigosertib Clinical Trials for Patients with Myelodysplastic Syndromes To Argentina, Chile, And Brazil For Preparation For Future Studies Of Oral Rigosertib",2018-08-21 08:34:00-04:00,ONTX,neutral
956922.0,Oncova Therapeutics shares are up 9.5% after the company beat Q2 earnings estimates.,2018-08-14 09:03:00-04:00,ONTX,positive
956923.0,"The Daily Biotech Pulse: Cesca, Acer Therapeutics Rally On Earnings, Aridis Makes Its Nasdaq Debut",2018-08-14 08:23:00-04:00,ONTX,neutral
956924.0,"Onconova Therapeutics Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $485K Beat $220K Estimate",2018-08-14 08:10:00-04:00,ONTX,neutral
956925.0,"Benzinga's Daily Biotech Pulse: Titan's Parkinson's Disease Drug Implant Trial, Juniper Pharma Sells Itself At 32% Premium",2018-07-03 07:51:00-04:00,ONTX,neutral
956926.0,"Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway",2018-05-15 08:44:00-04:00,ONTX,positive
956927.0,"Onconova Therapeutics Q1 EPS $(0.34) Beats $(0.39) Estimate, Sales $564K Beat $300K Estimate",2018-05-15 08:31:00-04:00,ONTX,neutral
956928.0,"The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More",2018-05-13 10:06:00-04:00,ONTX,neutral
956929.0,"Maxim Upgrades Onconova To Buy, Establishes $3 Price Target As Maxim Says The Co. Cleared A Major FInancing Roadblock, Believes Rigosertib Could Emerge As First Targeted Therapy Approved For MDS Based On Mechanism Of Action And Both Prior, Emerging Data",2018-05-02 13:48:00-04:00,ONTX,positive
956930.0,Maxim Group Upgrades Onconova Therapeutics to Buy,2018-05-02 13:45:00-04:00,ONTX,neutral
956931.0,Traders Circulating Chatter That Maxim Upgraded Shares Of Onconova,2018-05-02 13:34:00-04:00,ONTX,positive
956932.0,"Benzinga's Daily Biotech Pulse: Intra-cellular Moves On Poster Presentation, Earnings Beats From Vertex, Exact Sciences",2018-04-27 07:25:00-04:00,ONTX,neutral
956933.0,Onconova Therapeutics Prices Upsized Offering Of ~58.8M Shares Of Common Stock At $0.425/Share Plus Preferred Stock Warrant,2018-04-27 06:03:00-04:00,ONTX,positive
956934.0,"Benzinga's Daily Biotech Pulse: Catabasis Soars On Trial Results, Eloxx Listing, Biomarin Earnings",2018-04-26 08:07:00-04:00,ONTX,neutral
956935.0,"UPDATE: Onconova Says Next Major Milestone Is IND Filing In US, In By HanX In China",2018-04-19 08:35:00-04:00,ONTX,neutral
956936.0,Onconova Reports Presentation Of Data On CDK4/6 + ARK5 At AACR; Received Productive Pre-IND Guidance From FDA Related To ON 123300,2018-04-19 08:34:00-04:00,ONTX,neutral
956937.0,Onconova Therapeutics Shares Down 18.7% After Co. Filed For Offering Of 18.5M Units Consisting Of Common Stock And Warrants To Purchase 1 Share Of Common Stock,2018-04-18 12:25:00-04:00,ONTX,positive
956938.0,Onconova Therapeutics S-1 Shows Registration For Up to ~18.5M Unit Consisting Of Common Shares And Warrants To Buy 1 Share Of Common Stock,2018-04-17 17:35:00-04:00,ONTX,positive
956939.0,Onconova Announces 'Promising' Data from a Phase 2 Expansion Study of Oral Rigosertib and Azacitidine Combination,2018-03-26 08:37:00-04:00,ONTX,neutral
956940.0,"Onconova Therapeutics Reports FY17 EPS $(2.68) vs $(2.82) Est., Sales $787K vs $850K Est.",2018-03-08 07:03:00-05:00,ONTX,neutral
956941.0,Onconova Therapeutics Shares Up 18.4% Premarket Following Announcement That Co. Has Entered License Agreement With Pint Pharma To Commercialize Rigosertib In Latin America,2018-03-05 08:53:00-05:00,ONTX,positive
956942.0,"Onconova Therapeutics Announces License Agreement with Pint Pharma to Commercialize Rigosertib in Latin America, Pint to Make $2.5M Investment In Onconova, Co. Will Also Be Eligible to Receive Up To $42.75M In Milestone Payments",2018-03-05 08:02:00-05:00,ONTX,positive
956943.0,Onconova Announces Presentation of Mechanism of Action Studies of Rigosertib Combination with Azacitidine at AACR Epigenetics Conference,2018-03-04 16:34:00-05:00,ONTX,neutral
956944.0,683 Capital Management Llc Reports 21.8% Stake In Onconova Therapeutics Inc As Of Feb 8 -13D,2018-02-16 17:15:00-05:00,ONTX,neutral
956945.0,Onconova Therapeutics Prices 8.65M Share Offering At $1.01/Share,2018-02-08 06:08:00-05:00,ONTX,positive
956946.0,Onconova Therapeutics Amended S-1 Shows Registration For 8.65M Share Common Stock Offering,2018-01-30 08:33:00-05:00,ONTX,positive
956947.0,Maxim Group Downgrades Onconova Therapeutics to Hold,2018-01-18 08:28:00-05:00,ONTX,neutral
956948.0,Hearing Maxim Downgraded Onconova From Buy To Hold,2018-01-17 14:06:00-05:00,ONTX,neutral
956949.0,38 Stocks Moving In Wednesday's Mid-Day Session,2018-01-17 12:28:00-05:00,ONTX,neutral
956950.0,"Onconova Therapeutics Shares Up 30% After Open Following Earlier News Co. Will Move Forward With Phase 3 INSPIRE Trial, Raised Patient Size From 225 To 360 Patients",2018-01-17 09:55:00-05:00,ONTX,positive
956951.0,"Onconova Moving Forward with Phase 3 INSPIRE Pivotal Trial, Increases Patient  Size From 225 To 360 Patients, Predefined Subgroup Of Very High Risk Patients Constitutes Greater Than 70% Of Patients Enrolled To Date",2018-01-17 07:32:00-05:00,ONTX,positive
956952.0,Onconova Therapeutics Reports Cooperative R&D Deal For Rigosertib With National Cancer Institute,2018-01-04 08:03:00-05:00,ONTX,negative
956953.0,Onconova Therapeutics Announces a License and Collaborative Development Agreement with HanX Biopharma to Commercialize ON 123300 in Greater China and Fund Investigational New Drug Applications in the US and China,2017-12-19 07:35:00-05:00,ONTX,positive
956954.0,Onconova Gives an Update on Rigosertib in Myelodysplastic Syndromes,2017-12-12 08:31:00-05:00,ONTX,neutral
956955.0,"Onconova Therapeutics Reports Publication Of Results From Phase 1/2 Study Of Rigosertib, Says Rigosertib Reduced or Stabilized Bone Marrow Blasts and Improved Peripheral Blood Counts",2017-11-15 08:33:00-05:00,ONTX,positive
956956.0,Onconova Therapeutics Prices 920K Share Offering at $1.50/Share,2017-11-10 07:02:00-05:00,ONTX,positive
956957.0,Onconova Therapeutics Reports Q3 EPS $(0.71) vs $(0.68) Est.,2017-11-09 07:16:00-05:00,ONTX,neutral
956958.0,30 Stocks Moving In Thursday's Pre-Market Session,2017-10-12 08:03:00-04:00,ONTX,neutral
956959.0,Mid-Afternoon Market Update: Cleantech Solutions Gains After Exclusivity Agreement For Potential Takeover Of Inspirit Studio; 22nd Century Group Shares Drop,2017-10-09 14:31:00-04:00,ONTX,positive
956960.0,15 Biggest Mid-Day Gainers For Monday,2017-10-09 12:29:00-04:00,ONTX,neutral
956961.0,"Benzinga's Top Upgrades, Downgrades For October 9, 2017",2017-10-09 09:15:00-04:00,ONTX,positive
956962.0,"H.C. Wainwright Initiates Coverage On Onconova Therapeutics with Buy Rating, Announces $6.00 Price Target",2017-10-09 08:13:00-04:00,ONTX,neutral
956963.0,Cellectar Reports Strategic Collab. With Onconova Therapeutics Related To Developing Of New Phospholipid Drug Conjugates,2017-09-21 08:38:00-04:00,ONTX,neutral
956964.0,"Onconova Therapeutics Q2 EPS $(0.29) vs $(0.73) Est., Sales $324K vs $220K Est.",2017-08-15 07:03:00-04:00,ONTX,neutral
956965.0,"Onconova Therapeutics Reports Establishing Of Collaborative Research, Clinical Programs Evaluating Rigosesrtib In Pediatric 'RASopathies'",2017-07-25 08:33:00-04:00,ONTX,neutral
956966.0,Onconova Therapeutics Report Phase 2 Data in Rigosertib Treated Patients with Second-Line Myelodysplastic Syndromes at ASCO: 22% of patients achieved marrow complete response and 47% of patients in the study achieved disease stabilization,2017-06-05 08:31:00-04:00,ONTX,neutral
956967.0,"Onconova Therapeutics Reports Q1 EPS $(1.23) vs $(1.01) Est., Sales $210K vs $160K Est.",2017-05-15 08:36:00-04:00,ONTX,neutral
956968.0,13G from Sabby Mgmt on Onconova Theapeutics Shows New 8.55% Stake,2017-05-01 12:30:00-04:00,ONTX,neutral
956969.0,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Werner Enterprises Shares Spike Higher,2017-04-21 14:33:00-04:00,ONTX,negative
956970.0,15 Biggest Mid-Day Losers For Friday,2017-04-21 13:31:00-04:00,ONTX,negative
956971.0,Onconova Therapeutics Prices 2.47M Share Offering At $2.10/Share,2017-04-21 09:41:00-04:00,ONTX,positive
956972.0,25 Stocks Moving In Friday's Pre-Market Session,2017-04-21 08:31:00-04:00,ONTX,neutral
956973.0,Onconova Therapeutics Announces Proposed Public Offering of Common Stoc,2017-04-21 04:04:00-04:00,ONTX,neutral
956974.0,18 Biggest Mid-Day Gainers For Tuesday,2017-04-04 12:38:00-04:00,ONTX,neutral
956975.0,"Onconova Therapeutics FY16 EPS $(4.44) vs. $(10.54) YoY, Sales $5.54M vs. $11.45M YoY",2017-03-27 07:00:00-04:00,ONTX,neutral
956976.0,"Earnings Scheduled For March 27, 2017",2017-03-27 05:38:00-04:00,ONTX,neutral
956977.0,"Onconova Therapeutics Reports Q3 EPS $(0.29) vs. Prior Year Quarter $(2.60), Rev. $1.65M vs. Prior Year Quarter $1.62M",2016-11-14 07:13:00-05:00,ONTX,neutral
956978.0,Onconova Therapeutics Scheduled To Hold A Webcast With Key Opinion Leaders At 12 noon EST,2016-10-17 08:10:00-04:00,ONTX,neutral
956979.0,"Onconova Therapeutics Q2 EPS ($1.96), Revenue $2.25M vs $1.40M est",2016-08-15 07:07:00-04:00,ONTX,neutral
956980.0,Onconova Reports Enrollment of First Patient in Japan by SymBio,2016-07-19 07:09:00-04:00,ONTX,neutral
956981.0,Onconova Presents Clinical Data from Oral Rigosertib and Azacitidine Combination Study in Higher-Risk Myelodysplastic Syndromes at EHA Annual Meeting,2016-06-13 08:04:00-04:00,ONTX,neutral
956982.0,"Onconova Therapeutics Reports Effective Date of 1-for-10 Reverse Split: Jun. 1, '16",2016-05-20 08:01:00-04:00,ONTX,positive
956983.0,Onconova Therapeutics Reports Q1 EPS $(0.27) vs Est $(0.19),2016-05-11 16:08:00-04:00,ONTX,neutral
956984.0,"Onconova Reports Novel Dual Targeting of ARK5, CDK4/6 by Pre-Clinical Compound, ON 123300 at AACR",2016-04-20 08:33:00-04:00,ONTX,positive
956985.0,"Onconova Therapeutics Reports FY15 EPS $(1.05) vs. Prior Year Quarter $(2.94), Rev. $11.45M vs. Prior Year Quarter $800K",2016-03-28 08:04:00-04:00,ONTX,neutral
956986.0,Onconova Enrolls First Patient in Europe for Phase 3 INSPIRE Trial of Rigosertib in Higher-Risk Myelodysplastic Syndromes,2016-03-21 07:02:00-04:00,ONTX,positive
956987.0,"Onconova Reports Publication of Rigosertib Phase 3 ONTIME Data in Lancet Oncology, New Phase 3 ""INSPIRE"" Study Of IV Rigosertib Currently Enrolling Patients",2016-03-09 07:02:00-05:00,ONTX,neutral
956988.0,Onconova Therapeutics reports Registered Direct Offering for Gross Proceeds ~$1.84M; Co. to Issue ~1.9M Common Shares at $0.95/Share,2016-01-06 08:49:00-05:00,ONTX,negative
956989.0,Morning Market Gainers,2015-12-08 09:46:00-05:00,ONTX,neutral
956990.0,Benzinga's Top #PreMarket Gainers,2015-12-08 08:07:00-05:00,ONTX,positive
956991.0,Onconova +52% Premarket @$2.00; Company Presented Positive Data Monday from Phase 2 Combination Trial of Oral Rigosertib and Azacitidine at #ASH2015,2015-12-08 07:39:00-05:00,ONTX,positive
956992.0,Onconova Presents Positive Data rom Phase 2 Combination Trial of Oral Rigosertib and Azacitidine at #ASH2015,2015-12-07 19:21:00-05:00,ONTX,positive
956993.0,Onicova Therapeutics 8-K Says FDA Placed A Full Clinical Hold On Briciclib,2015-12-04 17:08:00-05:00,ONTX,neutral
956994.0,"Onconova Therapeutics Reports Q3 EPS ($0.26) vs. Est. ($0.32), Rev. $1.622M vs. Est. $70K",2015-11-11 16:10:00-05:00,ONTX,neutral
956995.0,Morning Market Gainers,2015-10-09 09:43:00-04:00,ONTX,neutral
956996.0,Onconova Therapeutics Reports Buyback Of $16.5M With Lincoln Park Capital FUnd,2015-10-08 16:56:00-04:00,ONTX,neutral
956997.0,Onconova Therapeutics Files European Clinical Trial Applications for Global Phase 3 Trial for IV Rigosertib in Higher-Risk Myelodysplastic Syndromes,2015-08-27 06:02:00-04:00,ONTX,neutral
956998.0,Morning Market Losers,2015-08-17 09:57:00-04:00,ONTX,negative
956999.0,Benzinga's Top #PreMarket Losers,2015-08-17 08:18:00-04:00,ONTX,negative
957000.0,Morning Market Gainers,2015-08-14 09:44:00-04:00,ONTX,neutral
957001.0,Onconova Therapeutics Shares Rise 56% Premarket as Co Announces Submission of Investigational NDA for Pivotal Phase 3 Trial for IV Rigosertib in Higher-Risk Myelodysplastic Syndromes,2015-08-14 08:32:00-04:00,ONTX,positive
957002.0,Benzinga's Top #PreMarket Gainers,2015-08-14 08:17:00-04:00,ONTX,positive
957003.0,"Onconova Therapeutics Reports Q2 EPS $(0.41) vs. Est. $(0.56), Rev. $123K vs. Est. $70K",2015-08-13 08:04:00-04:00,ONTX,neutral
957004.0,"Onconova Shares Quiet Post Market Following 8-K from Co. Showing Mgmt Sees Cash, Cash Equivalents as of Jun. 30 ~$25.4M",2015-07-08 16:23:00-04:00,ONTX,positive
957005.0,Benzinga's Top Upgrades,2015-07-01 09:40:00-04:00,ONTX,positive
957006.0,Piper Jaffray Upgrades Onconova Therapeutics To  Overweight,2015-07-01 09:32:00-04:00,ONTX,negative
957007.0,Piper Jaffray Upgrades Onconova Therapeutics to Overweight,2015-07-01 09:16:00-04:00,ONTX,negative
957008.0,"Piper Jaffray Upgrades Onconova Therapeutics to Overweight, Raises PT to $6.00",2015-07-01 07:18:00-04:00,ONTX,negative
957009.0,Onconova Presents Patient Selection Criteria and Intermediate Clinical Endpoints for Rigosertib in Higher-Risk Myelodysplastic Syndromes (HR-MDS) at EHA Annual Meeting,2015-06-15 08:03:00-04:00,ONTX,neutral
957010.0,Onconova Presents Clinical Data on Rigosertib in Higher-Risk Myelodysplastic Syndromes (HR-MDS) at the 2015 ASCO Annual Meeting,2015-06-01 08:12:00-04:00,ONTX,neutral
957011.0,"Onconova Therapeutics Reports Q1 Loss of $0.57/Share vs Loss of $0.63/Share Est., Sales $114K",2015-05-14 16:15:00-04:00,ONTX,negative
957012.0,Benzinga's Top Initiations,2015-05-05 09:34:00-04:00,ONTX,positive
957013.0,H.C Wainwright Initiates Onconova Therapeutics At Buy,2015-05-05 09:24:00-04:00,ONTX,neutral
957014.0,"H.C Wainwright Initiates Coverage on Onconova Therapeutics at Buy, Announces $6.00 PT",2015-05-05 07:09:00-04:00,ONTX,neutral
957015.0,"Onconova Therapeutics, Inc. Submits Pivotal Clinical Trial Protocol for IV Rigosertib in Higher-Risk Myelodysplastic Syndromes to FDA and EMA",2015-04-20 08:02:00-04:00,ONTX,neutral
957016.0,"Onconova Therapeutics Reports Q4 Revs $0.1M, No Estimates Avilable",2015-03-26 16:03:00-04:00,ONTX,negative
957017.0,Stocks Hitting 52-Week Lows,2015-02-17 10:15:00-05:00,ONTX,negative
957018.0,Stocks Hitting 52-Week Lows,2015-02-03 10:28:00-05:00,ONTX,negative
957019.0,Onconova Reports Clinical Development Plan for Rigosertib for HR-MDS Patients,2015-02-02 16:02:00-05:00,ONTX,neutral
957020.0,Onconova Therapeutics Appoints Dr. Steven Fruchtman as Chief Medical Officer,2015-01-12 17:06:00-05:00,ONTX,neutral
957021.0,Onconova Presents Data from Clinical Trials of Rigosertib in Myelodysplastic Syndromes at ASH Annual Meeting,2014-12-07 21:08:00-05:00,ONTX,neutral
957022.0,Onconova Presents Data from Combination of Rigosertib and Azacitidine in MDS and Non-proliferative AML at ASH Annual Meeting,2014-12-07 16:19:00-05:00,ONTX,positive
957023.0,"S-3 from Onconova Therapeutics Shows $100M Mixed Securities Shelf Offering, Selling Holders Will Sell Up to ~228.6K Shares",2014-10-08 17:27:00-04:00,ONTX,positive
957024.0,Onconova Reports Q2 EPS of $(0.77) vs $(0.87) Est; Revenue of $100.0K vs $560.0K Est,2014-08-13 16:18:00-04:00,ONTX,neutral
957025.0,Onconova Says Will File For Shelf,2014-07-10 16:34:00-04:00,ONTX,neutral
957026.0,"Stocks To Watch For June 26, 2014",2014-06-26 08:12:00-04:00,ONTX,neutral
957027.0,"Mid-Day Market Movers For Thursday, June 12, 2014",2014-06-12 13:05:00-04:00,ONTX,neutral
957028.0,Stocks Hitting 52-Week Lows,2014-04-03 10:32:00-04:00,ONTX,negative
957029.0,Stocks Hitting 52-Week Lows,2014-03-24 10:20:00-04:00,ONTX,negative
957030.0,Onconova Reports Q4 EPS of $(0.68) vs $(1.07) Est; Revenue of $1.93M vs $1.07M Est,2014-03-10 16:04:00-04:00,ONTX,neutral
957031.0,Stocks Hitting 52-Week Lows,2014-03-07 10:45:00-05:00,ONTX,negative
957032.0,Stocks Hitting 52-Week Lows,2014-02-20 10:02:00-05:00,ONTX,negative
957033.0,UPDATE: Piper Jaffray Downgrades Onconova Therapeutics as Lead Indication Failure Raises Doubts on Rigo,2014-02-20 08:33:00-05:00,ONTX,negative
957034.0,Benzinga's Top #PreMarket Losers,2014-02-20 08:20:00-05:00,ONTX,negative
957035.0,"Janney Capital Downgrades Onconova to Neutral, Lowers PT to $10.00",2014-02-20 08:01:00-05:00,ONTX,negative
957036.0,"Piper Jaffray Downgrades Onconova to Neutral, Lowers PT to $9.00",2014-02-20 07:27:00-05:00,ONTX,negative
957037.0,"#PreMarket Primer: Thursday, February 20: Facebook Makes Big Purchase With WhatsApp",2014-02-20 07:20:00-05:00,ONTX,neutral
957038.0,"Shares of Onconova Therapeutics Resume Trade, Now Down ~47%",2014-02-19 16:33:00-05:00,ONTX,positive
957039.0,Onconova Announces Results From Phase 3 ONTIME Trial of Rigosertib in Higher Risk Myelodysplastic Syndromes (MDS; Did Not Meet Primary Endpoint,2014-02-19 16:28:00-05:00,ONTX,negative
957040.0,Shares of Onconova Therapeutics to Resume Trade at 4:30PM EST,2014-02-19 16:26:00-05:00,ONTX,positive
957041.0,Onconova Announces Results From Phase 3 ONTIME Trial of Rigosertib in Higher Risk Myelodysplastic Syndromes (MDS),2014-02-19 16:18:00-05:00,ONTX,negative
957042.0,Morning Market Losers ,2013-12-18 10:02:00-05:00,ONTX,negative
957043.0,Benzinga's Top #PreMarket Losers,2013-12-18 08:37:00-05:00,ONTX,negative
957044.0,"Onconova Reports Combination of Rigosertib, Gemcitabine Unlikely to Demonstrate Statistically Significant Improvement i",2013-12-17 16:47:00-05:00,ONTX,positive
957045.0,Onconova Presents Positive Data from Clinical Trials of Rigosertib in MDS at ASH,2013-12-09 07:14:00-05:00,ONTX,positive
957046.0,UPDATE: Citigroup Upgrades Onconova Therapeutics on Favorable Risk-Reward,2013-10-29 10:59:00-04:00,ONTX,positive
957047.0,Benzinga's Top Upgrades,2013-10-29 07:40:00-04:00,ONTX,positive
957048.0,"Citigroup Upgrades Onconova to Buy, Lowers PT to $27.00",2013-10-29 07:11:00-04:00,ONTX,negative
957049.0,Stocks Hitting 52-Week Lows,2013-10-25 10:16:00-04:00,ONTX,negative
957050.0,Stocks Hitting 52-Week Lows,2013-10-22 10:13:00-04:00,ONTX,negative
957051.0,UPDATE: Piper Jaffray Initiates Onconova Therapeutics with Overweight on Multiple Positive Factors,2013-08-19 10:38:00-04:00,ONTX,positive
957052.0,"Citigroup Initiates Coverage on Onconova at Neutral, Announces $30.00 PT",2013-08-19 09:25:00-04:00,ONTX,neutral
957053.0,"Leerink Swann Initiates Coverage on Onconova at Outperform, Announces $37.00 PT",2013-08-19 09:24:00-04:00,ONTX,neutral
957054.0,"Janney Capital Initiates Coverage on Onconova at Buy, Announces $40.00 PT",2013-08-19 09:23:00-04:00,ONTX,neutral
957055.0,Benzinga's Top Initiations,2013-08-19 07:46:00-04:00,ONTX,positive
957056.0,"Piper Jaffray Initiates Coverage on Onconova at Overweight, Announces $38.00 PT",2013-08-19 07:42:00-04:00,ONTX,negative
957057.0,Benzinga's Volume Movers,2013-08-05 10:34:00-04:00,ONTX,neutral
957058.0,Shares of Onconova Therapeutics Open for Trade at $25 After Pricing at $15/Share,2013-07-25 10:40:00-04:00,ONTX,positive
957059.0,Shares of Onconova Therapeutics to Open for Trade at 10:40AM EDT; Co. Priced 5.17M Shares at $15/Share,2013-07-25 10:39:00-04:00,ONTX,positive
957060.0,A Peek Into The Market Before The Trading Starts,2013-07-25 07:29:00-04:00,ONTX,neutral
957061.0,Onconova Prices 5.166M Share IPO at $15.00/Share,2013-07-25 07:05:00-04:00,ONTX,positive
